MYGN Financial Facts
Total revenue: 177.5MOperating income: 6.2M
See Full Income Statement
Commitments and contingencies (Note 13): 0
Inventory, net: 53.9M
See Full Balance Sheet
Myriad Genetics Inc. (MYGN) Earnings
|
Expand Research on MYGN
| Next EPS Date | 5/2/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +96.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/13/19 |  |
Q419 | $0.41 | $0.47 | -$0.06 | $215.4M | $221.04M |  |
 | | Details |
| 5/7/19 | Q319 | $0.46 | $0.42 | +$0.04 | $216.6M | $217.46M | = | | | Details | |
| 2/5/19 | |
Q219 | $0.38 | $0.41 | -$0.03 | $216.8M | $216.73M | = | | | Details |
| 2/6/20 | |
Q220 | $0.23 | $0.31 | -$0.08 | $195.1M | $209.81M | |
| | Details |
| 11/6/18 | |
Q119 | $0.43 | $0.30 | +$0.13 | $202.3M | $202.37M | = | | | Details |
| 11/4/19 | |
Q120 | $0.08 | $0.32 | -$0.24 | $186.3M | $202.1M | |
| | Details |
| 8/21/18 | |
Q418 | $0.38 | $0.33 | +$0.05 | $200.9M | $195.76M | = | | | Details |
| 2/27/24 | Q423 | $0.04 | $0.01 | +$0.03 | $196.6M | $194.8M | N/A | | | Details |
